Back to dashboard
CommercialCoverageHigh impact

Radiofrequency Facet and Sacroiliac Joint Ablation/ Denervation 7.01.42

Excellus BlueCross BlueShield·Orthopedics, Pain Management, Neurosurgery +1 more·Bone & Joints (Orthopedic)
Effective date
Oct 15, 2025
We identified it
Jun 20, 2026
Days to comply

Summary

Excellus BlueCross BlueShield has updated their policy for radiofrequency facet and sacroiliac joint ablation/denervation, effective October 15, 2025. The policy establishes specific criteria for initial and repeat procedures, including requirements for 3+ months of pain, 4+ weeks of conservative treatment, positive response to two diagnostic injections with 80% pain relief, and mandatory 6-month intervals between repeat procedures.

Action Required

Action needed
Before October 15, 2025: Billing and clinical teams must update prior authorization workflows for Excellus BCBS radiofrequency ablation procedures. Ensure documentation includes: 3+ months pain duration, 4+ weeks conservative treatment, two sequential diagnostic injections with 80% pain relief lasting minimum anesthetic duration, and unfused spinal segments. For repeat procedures, document 50% pain relief lasting 12+ weeks and minimum 6-month interval from prior procedure. Update encounter forms to capture these requirements. Claims missing these criteria will be denied.